Ongoing research is also investigating whether GLP-1s may have neuroprotective effects, with early data suggesting possible benefits in Alzheimers and Parkinsons disease
Beyond Supplements: Lifestyle Habits to Support NAD+ and Glutathione While supplementation is a powerful tool, it works best when integrated into a healthy lifestyle
Ipamorelin, a new growth hormone releasing peptide in humans
Early research suggests transdermal GLP-1 delivery may provide consistent hormone levels, though clinical efficacy varies significantly based on individual biomarkers, baseline metabolic health, and adherence patterns
Why this approval matters Saxenda was the first GLP-1 drug approved to help with weight loss in the U.S., originally approved in December 2014
Ipamorelin works by binding to IGF-1 receptors in the body and mimicking its effects on those receptors